Spyre Therapeutics
SYRE
SYRE
28 hedge funds and large institutions have $38M invested in Spyre Therapeutics in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+5
Holders Change %
+21.74%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
7
Increased
6
Reduced
7
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$2.16M |
| 2 |
2
Millennium Management
New York
|
$230K |
| 3 |
3
Goldman Sachs
New York
|
$212K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$0 |
| 5 |
5
Norges Bank
Oslo,
Norway
|
$387K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $5K | -$536 | -3 | -10% |
|
|
BIM
27
BlackRock Investment Management
Wilmington,
Delaware
| $5K | – | – | – |
|
28
Bank of America
Charlotte,
North Carolina
| $3K | -$2.67K | -16 | -47% |
|
|
29
Citadel Advisors
Miami,
Florida
| – | -$62K | -514 | Closed |
|
30
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$4K | -37 | Closed |
|